Literature DB >> 34777547

Primary lung tumour invading the chest wall.

Mark Charnock1.   

Abstract

INTRODUCTION: This case study describes a primary lung tumour invading the chest wall, that clinically was thought likely to be a lipoma, and was imaged first using ultrasound. CASE REPORT: A 67 year old male presented to his GP with a six month history of a lump increasing in size on the left upper chest wall. The ultrasound scan demonstrated a hypoechoic and hypervascular soft tissue mass, extending out of the chest into the subcutaneous tissue and starting to erode the overlying rib. The appearances were highly suspicious for a chest malignancy. Further imaging and an ultrasound guided biopsy confirmed the diagnosis of a squamous cell carcinoma. DISCUSSION: The majority of patients who present to their general practitioner with a soft tissue mass commonly have benign abnormalities such as a lipoma or epidermoid cyst. Tumours of the chest wall are varied and are divided into benign and malignant tumours, and those that arise from the rib cage. Primary lung tumours are uncommonly seen on ultrasound. Lung cancers account for around 20% of all cancer deaths and the chest wall is involved in around 5% of primary lung tumours.
CONCLUSION: This case highlights the need for prompt investigation of enlarging superficial masses. Ultrasound imaging offers excellent detail for superficial structures and in this case, due to the location of the mass, identified a primary lung tumour.
© The Author(s) 2021.

Entities:  

Keywords:  Musculoskeletal; lung cancer; squamous cell carcinoma; ultrasound

Year:  2021        PMID: 34777547      PMCID: PMC8579374          DOI: 10.1177/1742271X20979731

Source DB:  PubMed          Journal:  Ultrasound        ISSN: 1742-271X


  8 in total

1.  Thoracic wall ultrasonography - normal and pathological findings. Pictorial essay.

Authors:  Romeo Chira; Alexandra Chira; Petru Adrian Mircea
Journal:  Med Ultrason       Date:  2011-09       Impact factor: 1.611

Review 2.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

3.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Hossein Borghaei; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Inga T Lennes; Billy W Loo; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Mary C Pinder-Schenck; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Scott J Swanson; Douglas E Wood; Stephen C Yang; Miranda Hughes; Kristina M Gregory
Journal:  J Natl Compr Canc Netw       Date:  2012-10-01       Impact factor: 11.908

Review 4.  Treatment of advanced squamous cell carcinoma of the lung: a review.

Authors:  Benjamin A Derman; Kathryn F Mileham; Philip D Bonomi; Marta Batus; Mary J Fidler
Journal:  Transl Lung Cancer Res       Date:  2015-10

5.  Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer.

Authors:  Juan P Wisnivesky; Jacqueline Arciniega; Grace Mhango; John Mandeli; Ethan A Halm
Journal:  Thorax       Date:  2010-12-02       Impact factor: 9.139

Review 6.  Primary lung tumors invading the chest wall.

Authors:  Pier Luigi Filosso; Alberto Sandri; Francesco Guerrera; Paolo Solidoro; Giulia Bora; Paraskevas Lyberis; Enrico Ruffini; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  The usefulness of thoracic ultrasonography in diagnosis and staging of bronchogenic carcinoma.

Authors:  Manal R Hafez; Eman Sm Sobh; Sawsan B Elsawy; Omaima I Abo-Elkheir
Journal:  Ultrasound       Date:  2017-08-03

Review 8.  Update on the Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in New Era of Personalized Medicine.

Authors:  Sara Victoria Soldera; Natasha B Leighl
Journal:  Front Oncol       Date:  2017-03-27       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.